Sacubitril/Valsartan and Heart Failure, Prior SARS-CoV-2 Infection and Breakthrough Infection Following mRNA Vaccination, COVID-19 and In-Hospital Mortality With Myocardial Infarction, and more
Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the November 16, 2021 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 16, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Cardiology : Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction
Interview with Douglas L. Mann, MD, and Eugene Braunwald, MD, authors of Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. Hosted by Clyde Yancy, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 3, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Diabetes Core Update - November 2021
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - October 29, 2021 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
JAMA Cardiology : Transthyretin Amyloid Cardiomyopathy in Patients With Heart Failure With Preserved Ejection Fraction
Interview with Omar F. AbouEzzeddine, MDCM, MS and Margaret M. Redfield, MD, authors of Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 25, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Heart Failure Quality Improvement RCT, 7 vs 14 Days of Antibiotics for Male UTI, Does This Patient Have Hypertension?, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 27, 2021 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - July 27, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Cardiology : Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Heart Failure
Interview with Christopher Rush, PhD, author of Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction, and Viviany Taqueti, MD, author of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction—Common, Unrecognized, and Prevalent in Patients With or Without Epicardial CAD (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 23, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Cardiology : New York Heart Association Class vs Patient-Reported Outcomes in Heart Failure
Interview with Gregg C. Fonarow, MD, and Stephen J. Greene, MD, authors of Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction, and Paul A. Heidenreich, MD, MS, author of The Growing Case for Routine Collection of Patient-Reported Outcomes (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 24, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Diabetes Core Update Special Edition - SGLT2 Inhibitors Part 3: Beneficial Effects on Heart Failure Endpoints – March 2021
In this third episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the effects of the SGLT-2 inhibitors in heart failure in persons with and without diabetes. In episode 1, Drs. Russell and Skolnik discussed an overview of the CVOTs for the SGLT-2 inhibitors and in episode 2 they focused on renal outcomes. This special three-part series is supported by independent educational grant from AstraZeneca. For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community M...
Source: Diabetes Core Update - March 12, 2021 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diab Core Update Feb 2021
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - January 27, 2021 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update Special Edition: SGLT-2 inhibitors – Renal Effects– December 2020
In this second episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the renal effects of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association Guidelines and address practical issues about SGLT-2 inhibitor use. In episode 1, Drs. Russell and Skolnik discussed an overview of the CVOTs for the SGLT-2 inhibitors and in episode 3 they will focus heart failure outcomes. This special three-part series is supported by independent educational grant from AstraZeneca. For more information about each of ADA’s science and medical journals, pleas...
Source: Diabetes Core Update - December 3, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
JAMA Cardiology : Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population
Interview with Anne Tybjærg-Hansen, MD, DMSc, author of Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 25, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Diabetes Core Update – December 2020
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - November 24, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Emergency Care Bundle for Heart Failure, AI Detection of Cancer Genes, Bladder Cancer Review, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 17, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 17, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Diabetes Core Update: SGLT-2 inhibitors – Cardiovascular Effects– Sept. 2020
In this first episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the Cardiovascular Outcome Trials (CVOTs) of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association Guidelines and answer some common practical questions about SGLT-2 inhibitor use. In episodes 2 and 3 of this series, Drs. Russell and Skolnik we will discuss the evidence about the effects of the SGLT-2 inhibitors on renal and heart failure outcomes. This special episode of the Diabetes Core Update was supported by an unrestricted educational grant from the Division...
Source: Diabetes Core Update - September 11, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Convalescent Plasma for COVID-19, Vitamin D for Depression, Management of Heart Failure with Reduced Ejection Fraction, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the August 4, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - August 4, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
